Nuvalent CFO sells 11,430 shares, exercises options
Nuvalent, Inc. Chief Financial Officer Alexandra Balcom exercised stock options and sold shares of Class A Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Nuvalent, Inc. Chief Financial Officer Alexandra Balcom exercised stock options and sold shares of Class A Common Stock. She exercised options to acquire 6,046 shares at $18.93 per share and 5,384 shares at $6.89 per share, then sold 11,430 shares in an open-market transaction at a weighted average price of $123.58 per share. These trades were executed under a Rule 10b5-1 trading plan adopted on December 23, 2025. Following the sale, she directly holds 85,533 shares of Class A Common Stock and retains stock options covering 22,933 and 8,016 shares with exercise prices of $18.93 and $6.89, respectively.
Insider Trade Summary 10b5-1
Exercise and Sale: 11,430 shares ($1.26M approx. pre-tax spread)
Exercise and Sale
5 txns
Insider
Balcom Alexandra
Role
Chief Financial Officer
Sold
11,430 shs ($1.41M)
Approx. gross sale proceeds
$1.41M
Approx. exercise cost
$152K
Approx. pre-tax spread
$1.26M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 5,384 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) | 6,046 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 5,384 | $6.89 | $37K |
| Exercise | Class A Common Stock | 6,046 | $18.93 | $114K |
| Sale | Class A Common Stock | 11,430 | $123.58 | $1.41M |
Holdings After Transaction:
Stock Option (Right to Buy) — 30,949 contracts (Direct);
Class A Common Stock — 85,533 shares (Direct)
Footnotes (3)
- F1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2025.
- F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.51 to $123.62, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price.
- F3. The shares underlying this option are fully vested.
Key Figures
Shares sold: 11,430 shares
Sale price: $123.58 per share
Shares held after sale: 85,533 shares
+4 more
7 metrics
Shares sold
11,430 shares
Class A Common Stock open-market sale on July 1, 2026
Sale price
$123.58 per share
Weighted average sale price, trades between $123.51 and $123.62
Shares held after sale
85,533 shares
Direct Class A Common Stock ownership following transactions
Options exercised
6,046 shares at $18.93
Stock option exercise into Class A Common Stock
Options exercised
5,384 shares at $6.89
Second stock option exercise into Class A Common Stock
Remaining option balance
22,933 shares at $18.93
Stock Option (Right to Buy), expires January 4, 2032
Remaining option balance
8,016 shares at $6.89
Stock Option (Right to Buy), expires April 29, 2031
Key Terms
Rule 10b5-1 trading plan, weighted average price, Stock Option (Right to Buy), Class A Common Stock, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.51 to $123.62, inclusive."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with underlying Class A Common Stock and specified exercise prices."
Class A Common Stock financial
"Transactions involved Class A Common Stock, including open-market sale and shares underlying exercised options."
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
Exercise or conversion of derivative security financial
"Transaction code M described as Exercise or conversion of derivative security for the stock options."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Nuvalent (NUVL) report for CFO Alexandra Balcom?
Nuvalent reported that CFO Alexandra Balcom exercised stock options to acquire 11,430 Class A shares and sold 11,430 shares in an open-market transaction. The sale used a weighted average price of $123.58 per share and was conducted under a Rule 10b5-1 trading plan.
What stock options did the Nuvalent (NUVL) CFO exercise in this Form 4?
The CFO exercised options for 6,046 shares at an exercise price of $18.93 and 5,384 shares at $6.89. These options were fully vested, resulting in 11,430 newly acquired Class A shares before the subsequent open-market sale reported.
What stock options does the Nuvalent (NUVL) CFO retain after these transactions?
After the exercises, the CFO retains stock options for 22,933 shares at a $18.93 exercise price expiring January 4, 2032, and 8,016 shares at a $6.89 exercise price expiring April 29, 2031, as reported for the remaining option holdings.
AI-generated analysis. How Rhea-AI works. Not financial advice.
